Oral submucous fibrosis
MONDO:0018166Oral submucous fibrosis (OSMF) is a chronic, progressive disease that alters the fibroelasticity of the oral submucosa, prevalent in India and Southeast Asia but rare elsewhere, and characterized by burning and pain in the oral cavity, loss of gustatory sensation, the presence of blanched fibrous bands and stiffening of the oral mucosa and oro-pharynx (leading to trismus and a progressive reduction in mouth opening) and an increased risk of developing oral squamous cell cancer (3-19%). It is usually associated with the chewing of the areca nut (an ingredient in betel quid) but the exact etiology is unknown and there is currently no effective treatment.
Also known as: OSMF, oral cavity submucous fibrosis, oral submucosal fibrosis, including of tongue
5 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could diabetes drug metformin help reverse mouth scarring?
Disease control CompletedThis completed Phase 1/2 trial tested whether metformin (a diabetes drug) and pirfenidone (an anti-scarring drug) can reduce fibrosis in people with oral submucous fibrosis, a condition that causes mouth stiffness and raises cancer risk. 45 participants received either metformin,…
Phase: PHASE1, PHASE2 • Sponsor: Ziauddin University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Jaw implants aim to boost life quality after surgery
Symptom relief CompletedThis study looked at how well Global D implants work for orthognathic (jaw) surgery and whether they improve patients' quality of life. 198 people who had their first jaw surgery received these implants. Researchers measured quality of life before and after surgery using a specia…
Sponsor: Global D • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC